Pathway,Score
Signaling by VEGF,0.07302138129173841
Negative regulation of the PI3K/AKT network,0.010729836784002723
PI3K/AKT Signaling in Cancer,0.07980994077021167
G beta:gamma signalling through PI3Kgamma,0.015402035962113729
G-protein beta:gamma signalling,0.0030291817866060053
VEGFA-VEGFR2 Pathway,-0.0009608894015061118
VEGFR2 mediated vascular permeability,0.0032445257181516083
Constitutive Signaling by AKT1 E17K in Cancer,0.019316863339699366
Respiratory Syncytial Virus Infection Pathway,0.01747239529210629
RSV-host interactions,0.009618876384305034
RHO GTPases Activate WASPs and WAVEs,-0.0197435820238188
RAC2 GTPase cycle,0.031393382380208425
RAC3 GTPase cycle,-0.05297237297260174
Parasite infection,0.06362809487310563
Leishmania phagocytosis,-0.01587310138973954
FCGR3A-mediated phagocytosis,-0.003397178573084237
Signaling by NOTCH1,-0.027672622509926133
NOTCH1 Intracellular Domain Regulates Transcription,-0.014692031996833284
Signaling by NOTCH1 PEST Domain Mutants in Cancer,0.01043527317047554
Signaling by NOTCH1 in Cancer,0.020743386068711758
Constitutive Signaling by NOTCH1 PEST Domain Mutants,-0.03142856537358271
Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer,-0.037599793870566015
Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants,0.009052024113955151
Regulation of PTEN gene transcription,0.030551959861953235
Budding and maturation of HIV virion,0.02670824310508526
Uptake and actions of bacterial toxins,0.020739931581075097
Bacterial Infection Pathways,-0.064215582099863
NRAGE signals death through JNK,-0.006911920550204224
p75 NTR receptor-mediated signalling,-0.021608416526737898
"Cell death signalling via NRAGE, NRIF and NADE",0.047768968938550295
Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models,0.003471836175454166
Neurodegenerative Diseases,0.03800449835456961
Diseases of programmed cell death,0.030434161263078532
Defective Intrinsic Pathway for Apoptosis,-0.005442995958553668
Signaling by SCF-KIT,-0.014549452480369492
Regulation of KIT signaling,0.082714359770803
Degradation of beta-catenin by the destruction complex,-0.006538189190676988
Beta-catenin phosphorylation cascade,0.008107961531272224
Disassembly of the destruction complex and recruitment of AXIN to the membrane,-0.005174900646053964
G alpha (12/13) signalling events,0.09255839343194286
Pre-NOTCH Transcription and Translation,-0.06100950923548127
Pre-NOTCH Expression and Processing,-0.06983872592818817
Signaling by NOTCH2,-0.028851425302437263
NOTCH2 intracellular domain regulates transcription,-0.06320389100213997
Signaling by NOTCH3,0.01805222387650812
NOTCH3 Intracellular Domain Regulates Transcription,-0.03646383719666655
Signaling by NOTCH4,-0.0310276930954586
NOTCH4 Intracellular Domain Regulates Transcription,-0.007566688231698466
Signaling by MET,0.09291419722959188
RAS processing,0.013551614471478943
Potential therapeutics for SARS,-0.009194257943969813
Host Interactions of HIV factors,-0.06935309995793766
Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters,0.019235592214122608
The role of Nef in HIV-1 replication and disease pathogenesis,0.021489267827606587
NR1H2 and NR1H3-mediated signaling,0.0035013209529589726
NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux,0.08120245607718707
Diseases of glycosylation,0.009163170370875828
Diseases associated with O-glycosylation of proteins,0.0038845759724164554
Defective GALNT3 causes HFTC,-0.020311054745088476
Defective GALNT12 causes CRCS1,0.011672555219465702
Diseases of metabolism,0.01537430039312478
Diseases of DNA repair,0.04806285349689578
Diseases of DNA Double-Strand Break Repair,-0.03041501422455823
Defective homologous recombination repair (HRR) due to BRCA2 loss of function,-0.02841292300549433
Defective homologous recombination repair (HRR) due to BRCA1 loss of function,-0.0008102705966879799
Defective homologous recombination repair (HRR) due to PALB2 loss of function,-0.012457790555115433
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA1 binding function,-0.006777700350923425
Defective HDR through Homologous Recombination Repair (HRR) due to PALB2 loss of BRCA2/RAD51/RAD51C binding function,-0.0057110701676051975
Impaired BRCA2 binding to RAD51,0.02711458608060184
Impaired BRCA2 binding to PALB2,0.01751950754582405
Effects of PIP2 hydrolysis,-0.016146741869889156
Integrin signaling,0.00769394210243757
Retrograde neurotrophin signalling,0.00025018614416486896
Signaling by NTRK1 (TRKA),-0.06640923320648831
TNFR1-induced proapoptotic signaling,-0.007653735010979989
Regulation of TNFR1 signaling,-0.05816895581118745
TNFR1-induced NF-kappa-B signaling pathway,0.06157433635817416
TNF signaling,0.06113369559275554
RHOA GTPase cycle,0.037849343936298276
SARS-CoV-2 activates/modulates innate and adaptive immune responses,0.02805787261657384
HCMV Infection,0.004813267098922089
HCMV Early Events,0.03339903854575054
Regulation of RAS by GAPs,-0.01565831616662633
RHOF GTPase cycle,-0.036770335611649455
P2Y receptors,-0.020135609937734333
Nucleotide-like (purinergic) receptors,-0.0024490279081767785
Signaling by PTK6,-0.005794468716908349
Signaling by Non-Receptor Tyrosine Kinases,0.00334252358475955
Signaling by Retinoic Acid,-0.08447154716090852
RA biosynthesis pathway,-0.04387480983403818
Signaling by ERBB2,0.015642298528585605
Downregulation of ERBB2 signaling,0.04136176381221
Activated NOTCH1 Transmits Signal to the Nucleus,-0.0008305423710517374
NOTCH2 Activation and Transmission of Signal to the Nucleus,0.1599156066171988
NOTCH3 Activation and Transmission of Signal to the Nucleus,0.04801294890237015
Opioid Signalling,-0.012058357392597282
DARPP-32 events,0.03180140734551509
Nuclear Events (kinase and transcription factor activation),-0.04150392823942592
Signaling by NTRK2 (TRKB),-0.048996928536777395
NGF-stimulated transcription,-0.018354327802877754
Class B/2 (Secretin family receptors),0.059715074272668575
G alpha (s) signalling events,-0.05059222980828893
RHOB GTPase cycle,-0.008174854346858197
RHOC GTPase cycle,-0.03040325878892361
Vpu mediated degradation of CD4,0.007290075523564541
Vif-mediated degradation of APOBEC3G,-0.0037883914591439805
PCP/CE pathway,-0.02316383243524864
Asymmetric localization of PCP proteins,-0.0012956397868804839
Degradation of AXIN,0.06744162237497303
Degradation of DVL,-0.0031982603190418334
Hedgehog ligand biogenesis,-0.0889305916426958
Hh mutants are degraded by ERAD,-0.0029262344134647063
Hh mutants abrogate ligand secretion,-0.0010598036338425071
Degradation of GLI1 by the proteasome,0.007413146164345999
Degradation of GLI2 by the proteasome,-0.022597866182743877
GLI3 is processed to GLI3R by the proteasome,-0.04208684290225425
Hedgehog 'off' state,-0.016015189170030766
ABC transporter disorders,-0.005500571334977226
Disorders of transmembrane transporters,-0.03526735102788002
Hedgehog 'on' state,0.22862617478885155
Defective CFTR causes cystic fibrosis,0.24543108880408612
MAPK6/MAPK4 signaling,0.05357939930184644
Regulation of PTEN stability and activity,-0.023223252202433296
Negative regulation of NOTCH4 signaling,0.007481410129532835
Formation of HIV elongation complex in the absence of HIV Tat,-0.01718317384176076
Formation of the HIV-1 Early Elongation Complex,-0.023973452652072683
RNA Pol II CTD phosphorylation and interaction with CE during HIV infection,-0.010391901947909616
HIV Transcription Initiation,0.020296219303741335
RNA Polymerase II HIV Promoter Escape,-0.011319719395479043
HIV Transcription Elongation,-0.03620238707215347
Transcription of the HIV genome,0.05068083829797043
Formation of HIV-1 elongation complex containing HIV-1 Tat,-0.020518894686743866
Tat-mediated elongation of the HIV-1 transcript,-0.03909346901404876
RHOBTB3 ATPase cycle,0.009919695480024464
Signaling by TGF-beta Receptor Complex,0.25649137935031746
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer,-0.018186367657837137
SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription,-0.003834680511399834
Pausing and recovery of Tat-mediated HIV elongation,-0.0018179404418884194
Tat-mediated HIV elongation arrest and recovery,-0.03813802276970082
HIV elongation arrest and recovery,0.0031925837891026076
Pausing and recovery of HIV elongation,-0.0020382845252656695
Estrogen-dependent gene expression,0.0004160559119340242
RHOBTB2 GTPase cycle,0.11209345720304076
RHOBTB1 GTPase cycle,0.029180728450220978
RHOBTB GTPase Cycle,-0.05357088478557669
Signaling by EGFR,-0.0019412842760176347
EGFR downregulation,-0.005708768012852159
Signaling by FGFR,0.15393169062785475
Negative regulation of FGFR1 signaling,-0.0023032290056778934
Negative regulation of FGFR2 signaling,0.0006703723185583502
Negative regulation of FGFR3 signaling,-0.010683896725607383
Negative regulation of FGFR4 signaling,0.032569903269691315
Signaling by FGFR1,0.033370202359968196
Signaling by FGFR2,0.02764528226308781
Signaling by FGFR3,-0.03078116892367266
Signaling by FGFR4,0.0282390315504327
Negative regulation of MET activity,-0.003043668456682029
InlB-mediated entry of Listeria monocytogenes into host cell,0.10751287563332532
Listeria monocytogenes entry into host cells,0.009548126029958944
RHOU GTPase cycle,0.0313960075362875
MAP2K and MAPK activation,0.07185032163397964
Signaling by moderate kinase activity BRAF mutants,0.027014017043596975
Signaling by high-kinase activity BRAF mutants,0.0038465091863971596
Signaling by RAS mutants,0.0033973057461639373
Signaling by BRAF and RAF1 fusions,-0.005419992148449956
Paradoxical activation of RAF signaling by kinase inactive BRAF,0.027701426438464537
Oncogenic MAPK signaling,-0.027903152069277317
Signaling downstream of RAS mutants,0.008841330250328546
Signaling by RAF1 mutants,0.010501753346695111
AKT phosphorylates targets in the cytosol,-0.008647777389563072
Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects,-0.011294613676651345
"Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.031198469747186448
Diseases of mitotic cell cycle,-0.001371668783060244
FLT3 signaling in disease,-0.03301610515684871
Aberrant regulation of mitotic cell cycle due to RB1 defects,0.005737582476651821
Signaling by ALK in cancer,0.00040965958058069115
Signaling by FLT3 ITD and TKD mutants,-0.004174386975235569
Signaling by ALK fusions and activated point mutants,-0.019174370388221198
RHO GTPases activate CIT,0.033214877022589503
Extra-nuclear estrogen signaling,0.005592347175306508
Estrogen-dependent nuclear events downstream of ESR-membrane signaling,-0.004955180541486617
Signaling by Activin,0.003078146577278876
Downregulation of TGF-beta receptor signaling,-0.024175582409550082
TGF-beta receptor signaling activates SMADs,0.020229160773043948
G alpha (z) signalling events,-0.050724703807370264
Activation of RAC1,-0.0015256294528226521
RHOQ GTPase cycle,-0.06209615905570419
RHOH GTPase cycle,-0.0305475427597821
RHOG GTPase cycle,-0.01706292639318053
RHOJ GTPase cycle,0.08729806989580598
RHOV GTPase cycle,0.0014454751738688845
Signaling by Insulin receptor,0.007309727599467602
Insulin receptor recycling,0.001437888021623119
MET activates PTK2 signaling,-0.001853761580024314
MET promotes cell motility,-0.14095547436076916
MTOR signalling,-0.0016879178168071717
mTORC1-mediated signalling,-0.0007507141488148245
Energy dependent regulation of mTOR by LKB1-AMPK,0.00938215237164671
Diseases of Immune System,0.05323150807595395
Diseases associated with the TLR signaling cascade,-0.003445642459566293
RHO GTPases activate IQGAPs,-0.0031240675528255513
RHO GTPases Activate Formins,0.03714443963483207
RHO GTPases activate PKNs,-0.036825311089444285
RHO GTPases Activate ROCKs,-0.024302196427870668
RHO GTPases activate PAKs,-0.02694345542382183
Aberrant regulation of mitotic exit in cancer due to RB1 defects,-7.605451189323986e-06
Pre-NOTCH Processing in Golgi,0.016363629746908574
Signaling by ERBB4,-0.013818174300075816
Nuclear signaling by ERBB4,-0.0033468306075736384
Signaling by Hippo,0.01689109724780349
RHOD GTPase cycle,-0.019186153179293754
SARS-CoV-1-host interactions,-0.08368853914210816
SARS-CoV-1 activates/modulates innate immune responses,-0.014264630233748339
RND3 GTPase cycle,0.06950579590679203
Nuclear events stimulated by ALK signaling in cancer,-0.021994617872016335
HCMV Late Events,-0.016687162313846714
Formation of the beta-catenin:TCF transactivating complex,0.1321414383748438
Peptide ligand-binding receptors,-0.014765776539987797
Chemokine receptors bind chemokines,0.0019017430973224515
Translation of Structural Proteins,0.00835981660723354
Maturation of spike protein,0.050294002297358004
Late SARS-CoV-2 Infection Events,-0.11443087788417722
Purinergic signaling in leishmaniasis infection,-0.002076017626963659
Cell recruitment (pro-inflammatory response),0.019788405776790037
CaMK IV-mediated phosphorylation of CREB,0.015013448754413412
Calmodulin induced events,-0.0034588863300330933
Ca-dependent events,0.024760225143761184
CaM pathway,-0.016989765534516584
G-protein mediated events,0.0021517311176913636
PLC beta mediated events,-0.01012702626761243
DAG and IP3 signaling,0.0002626831488861332
G-protein activation,-0.00350900848105345
Ca2+ pathway,-0.043390586251066184
G beta:gamma signalling through PLC beta,0.00790740408969503
Glucagon-type ligand receptors,0.0944971438308522
G beta:gamma signalling through BTK,-0.05250526779433183
G beta:gamma signalling through CDC42,-0.01500129848462947
GPER1 signaling,0.0022466217857521602
ADORA2B mediated anti-inflammatory cytokines production,0.00019989839178107305
Anti-inflammatory response favouring Leishmania parasite infection,-0.03561111351094975
Leishmania parasite growth and survival,-0.01176195902553219
PKA-mediated phosphorylation of CREB,-0.026983746412461106
PKA activation,0.015359997741122351
Adenylate cyclase activating pathway,0.017387730822026444
Adenylate cyclase inhibitory pathway,-0.004208387728764101
FCGR3A-mediated IL10 synthesis,-0.017709546880864024
Signaling by ERBB2 in Cancer,0.009106768059112879
Constitutive Signaling by Aberrant PI3K in Cancer,0.0129092841767948
"PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",-0.06459699074227768
Signaling by ERBB2 KD Mutants,-0.00054786535984146
Signaling by ERBB2 TMD/JMD mutants,-0.002040135348150872
RND2 GTPase cycle,0.0342447333460554
Signaling by TGFBR3,0.011220255422368732
Rev-mediated nuclear export of HIV RNA,-0.0006198398934655028
Transport of Ribonucleoproteins into the Host Nucleus,0.0035007443439384403
Export of Viral Ribonucleoproteins from Nucleus,-0.02071300950771617
NS1 Mediated Effects on Host Pathways,-0.011087314615795317
Viral Messenger RNA Synthesis,0.042577008120436924
NEP/NS2 Interacts with the Cellular Export Machinery,-0.007815355208214556
Interactions of Vpr with host cellular proteins,0.03349041700541448
Interactions of Rev with host cellular proteins,9.073659255961408e-05
Nuclear import of Rev protein,-0.09856237268867941
Vpr-mediated nuclear import of PICs,-7.246927616220136e-06
SLC transporter disorders,-0.049324857136122426
Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC),-0.01849390747211981
VEGFR2 mediated cell proliferation,-0.0017010779317360469
Eicosanoid ligand-binding receptors,-0.023270275178283395
RHO GTPases Activate NADPH Oxidases,-0.0022178661567168988
Downstream signaling of activated FGFR1,-0.013414942407974768
FRS-mediated FGFR1 signaling,-0.0026730633469683215
Downstream signaling of activated FGFR2,0.007143557695197514
FRS-mediated FGFR2 signaling,0.01453095053140286
FRS-mediated FGFR3 signaling,0.004350874490633054
Downstream signaling of activated FGFR3,-0.02839035550522411
FRS-mediated FGFR4 signaling,-0.020782156498024285
Downstream signaling of activated FGFR4,-0.019985966122168915
RND1 GTPase cycle,-0.07643683805820156
Signaling by FGFR in disease,0.010374863097927142
Prolonged ERK activation events,-0.0013316672469181005
Frs2-mediated activation,0.00422765452161919
Signalling to ERKs,-0.03813100681188374
Signaling by ALK,-0.026816134671394366
Signaling by FGFR2 in disease,-0.048857720015186144
Signaling by FGFR1 in disease,-0.01603600654761585
Signaling by FGFR3 in disease,0.00899158168349848
SARS-CoV-1 targets host intracellular signalling and regulatory pathways,0.006673362439023577
Activation of SMO,0.0003691727147907551
Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants,0.009359940718105742
Signaling by EGFR in Cancer,-0.0040419699266783515
Constitutive Signaling by EGFRvIII,-0.0037558988300506273
Signaling by EGFRvIII in Cancer,0.01840693047260045
Signaling by Ligand-Responsive EGFR Variants in Cancer,0.030973701998684086
Signaling by ERBB2 ECD mutants,0.01748132389576666
Infection with Mycobacterium tuberculosis,-0.00459752049368677
Response of Mtb to phagocytosis,-0.00924186420666263
Signaling by BMP,-0.007678223603829564
Early Phase of HIV Life Cycle,-0.018212807926744873
SARS-CoV-2 modulates host translation machinery,-0.005071212364798208
RAF-independent MAPK1/3 activation,-0.020762630234121227
Negative regulation of MAPK pathway,0.0038642159442511073
Viral mRNA Translation,-0.026434816177207703
Amine ligand-binding receptors,-0.03203309894935501
Neurotoxicity of clostridium toxins,0.03302220979293497
SARS-CoV-2 modulates autophagy,-0.014755950392172935
PI3K Cascade,-0.058577817030421156
IRS-mediated signalling,-0.019914545023865162
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R),0.0184095339275589
IGF1R signaling cascade,-0.009030852971023922
IRS-related events triggered by IGF1R,-0.012838510264723673
Insulin receptor signalling cascade,-0.005238307667261593
WNT5A-dependent internalization of FZD4,0.017022762111204338
"WNT5A-dependent internalization of FZD2, FZD5 and ROR2",-0.02065070428848461
Induction of Cell-Cell Fusion,-0.04231888586339839
Signaling by PDGF,0.07155279665467411
Translation of Replicase and Assembly of the Replication Transcription Complex,0.013002322002021003
Early SARS-CoV-2 Infection Events,0.029363763700834284
Assembly Of The HIV Virion,-0.025150224287085975
Evasion by RSV of host interferon responses,0.01487264456411425
Downstream signal transduction,0.0016114842958819336
p130Cas linkage to MAPK signaling for integrins,-0.015839919402682735
Signaling by Erythropoietin,0.0993381942377584
SARS-CoV-1 modulates host translation machinery,-0.00854144760864388
Downregulation of SMAD2/3:SMAD4 transcriptional activity,-0.0194889089470928
Maturation of nucleoprotein,0.005160592256977879
Signalling to RAS,0.004379963058999677
FGFR2 ligand binding and activation,-0.004654947853789875
Signaling by WNT in cancer,-0.011909620797267964
Signaling by AXIN mutants,0.03294674135663349
Signaling by CTNNB1 phospho-site mutants,-0.005417049485852951
Signaling by APC mutants,0.01336970141538617
Signaling by AMER1 mutants,0.006302056473872002
Signaling by GSK3beta mutants,-0.00806690971057388
CTNNB1 S33 mutants aren't phosphorylated,-0.012413960163953805
CTNNB1 S37 mutants aren't phosphorylated,0.021493740320248814
CTNNB1 S45 mutants aren't phosphorylated,0.012029800651554332
CTNNB1 T41 mutants aren't phosphorylated,0.0054463975732736356
APC truncation mutants have impaired AXIN binding,-0.04052206922940317
AXIN missense mutants destabilize the destruction complex,-0.018543150595695466
Truncations of AMER1 destabilize the destruction complex,-0.004151866628036795
"Respiratory syncytial virus (RSV) genome replication, transcription and translation",0.003329018812243125
Maturation of hRSV A proteins,-0.01946237574974063
RHO GTPases activate KTN1,-0.016481972928710814
Deactivation of the beta-catenin transactivating complex,0.008927678978677082
Repression of WNT target genes,0.02588250522040583
FGFR4 ligand binding and activation,-0.017625163437152522
Phospholipase C-mediated cascade; FGFR4,0.002191001097487351
SHC-mediated cascade:FGFR4,0.043473024140994694
PI-3K cascade:FGFR4,0.020587845444178625
STAT3 nuclear events downstream of ALK signaling,0.01924668208496211
Defective pyroptosis,-0.041132639344659556
ERK/MAPK targets,-0.011155531308320647
ERKs are inactivated,0.0077136006998370305
TGFBR3 expression,-0.03605771766072434
Erythropoietin activates Phosphoinositide-3-kinase (PI3K),0.00982710717192477
Class C/3 (Metabotropic glutamate/pheromone receptors),0.09642369042863459
FGFR1 mutant receptor activation,-0.0602859832400654
FGFR2 mutant receptor activation,0.041111398655848924
Activated point mutants of FGFR2,0.008111045005905482
Phospholipase C-mediated cascade; FGFR2,-0.011905447647813162
PI-3K cascade:FGFR1,-0.03433751616282863
PI-3K cascade:FGFR2,-0.04522525719288768
SHC-mediated cascade:FGFR2,0.0032807736365327547
Signaling by FGFR2 IIIa TM,-0.01215907520722764
TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition),-0.00012244095529862254
Abortive elongation of HIV-1 transcript in the absence of Tat,0.03540083940318069
FGFR2 alternative splicing,0.010752650077284159
Regulation of PTEN mRNA translation,0.030168172321070007
Competing endogenous RNAs (ceRNAs) regulate PTEN translation,0.021307441690151377
NRIF signals cell death from the nucleus,0.0008126824136487381
Signaling by KIT in disease,-0.017774448645230905
"Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",-0.007189214050439381
Loss of function of MECP2 in Rett syndrome,-9.04782698490586e-05
Pervasive developmental disorders,-0.00710331264249821
Disorders of Developmental Biology,0.018878195100019642
Disorders of Nervous System Development,0.02609235892055925
Defects in vitamin and cofactor metabolism,0.001812671512183965
Regulation of FZD by ubiquitination,-0.029501903539590604
Serotonin receptors,-0.0023572274155115956
p75NTR signals via NF-kB,0.008703060086580722
Signaling by NTRK3 (TRKC),-0.0015925614217046113
RAF activation,-0.003079823642018681
p75NTR regulates axonogenesis,0.005998604282055799
WNT ligand biogenesis and trafficking,-0.014542551148178548
